- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01397630
Accelerated Titration of Oxytocin for Nulliparous Patients With Labour Dystocia: ACTION Pilot Study (ACTION)
Accelerate Versus Gradual Titration of Oxytocin Dose for Labour Dystocia: A Pilot Study
The ultimate objective is to test the hypothesis that an 'accelerated titration' protocol for labour augmentation with oxytocin reduces the risk of caesarean births relative to a 'gradual titration' protocol.
The aims of this pilot feasibility are:
- To assess the feasibility of a large multi-centre randomized control trial comparing the two above oxytocin protocols (accelerated titration versus gradual titration for correction of dystocia).
- More specifically, to identify potential challenges in the study implementation, particularly with respect to patient recruitment, randomization, blinding, and compliance/adherence to the labour management guidelines and study protocols.
- To obtain preliminary data on the acceptability of the accelerated oxytocin titration protocol among obstetrical providers and participants.
Study Overview
Detailed Description
There has been a steady increase in the rate of Caesarean births in Canada and worldwide. Almost half of all primary caesarean sections are performed for labour dystocia - when labour is abnormally slow or when there is no further progression in cervical dilatation. When dystocia occurs, oxytocin is used to increase the frequency and intensity of uterine contractions, with the goal of achieving full cervical dilatation and a vaginal birth. The actual dose required to produce a clinical response (progressive cervical dilatation) varies greatly from patient to patient. There is a wide range of oxytocin regimens currently in use. They may be broadly categorized as being of two types: 1) those involving a gradual titration of oxytocin dose (or 'low dose') and 2) those with accelerated oxytocin titration (also called 'high dose').
In fact, the frequently used terms 'low dose' and 'high dose' are to a certain extent misnomers. Both protocols titrate oxytocin dose to achieve the desired 'physiological frequency' of uterine contractions (usually 4 to 5 contractions in a 10 minute interval) that are normally sufficient to result in progressive labour. Thus, the target dose should, theoretically, be identical and independent of the rate of increase of oxytocin. These protocols differ mainly in the rate at which the desired physiologic response is achieved. While most patients achieve a response to stimulation at oxytocin concentrations between 4 and 10 mU per minute, a proportion of nulliparae require higher doses of oxytocin. Accelerated titration protocols are also frequently associated with a higher maximum concentration of oxytocin. While, most Canadian birthing centres currently follow a 'gradual titration' or 'low dose' protocol, there is evidence that 'accelerated titration' or 'high dose' protocols may be more effective in correcting dystocia and in preventing caesarean section. It is postulated that by more rapidly progressing to the required therapeutic dose, cervical dilatation is achieved more rapidly, the likelihood of a spontaneous vaginal birth is increased, and the risk of occurrence of complications resulting from prolonged labour (such as infection and maternal fatigue) is reduced.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y 4E9
- The Ottawa Hospital Research Institute
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1C5
- Sainte-Justine Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Capability of participant to comprehend English and/or French and to comply with study requirements
- ≥ 18 years of age at time of consent
- Nulliparity
- Singleton pregnancy
- Cephalic Presentation
- No contraindications to trial of labour or vaginal birth
- Term pregnancy (37+0 to 42+0 weeks gestation)
- Spontaneous onset of labour
In the ACTIVE phase of the FIRST stage of labour. Active labour is defined as:
- The presence of regular uterine contractions
- Cervical dilatation of ≥ 3 cm
- Cervical effacement of at least 80% (cervical length < 1cm)
DYSTOCIA in the ACTIVE phase of FIRST stage of labour established by the Physician.
- Cervical change of < 0.5 cm/hour over four hours OR
- NO cervical change in 2 hours
- Ruptured amniotic membranes of at least 30 minutes
- Normal fetal heart rate pattern at the time of randomization
Exclusion Criteria:
- Serious medical condition (severe cardiac, pulmonary, or renal disease)
- Known fetal anomaly
- Known sensitivity to oxytocin
- Contraindications to labour or vaginal birth (uterine scar)
- Induced labour (using any method)
- Oxytocin use prior to randomization
- Second stage of labour
- Suspected IUGR (<5th percentile)
- Suspected macrosomia at term (>4500 grams)
- Oligohydramnios (no 2x2 pocket of fluid on ultrasound prior to rupture of amniotic membranes)
- Abnormal FHR pattern at the time of randomization
- Suspected chorioamnionitis
- Severe pre-eclampsia
- Suspected placental abruption
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Accelerated Oxytocin Titration
|
Accelerated Oxytocin Titration
Other Names:
|
ACTIVE_COMPARATOR: Gradual Oxytocin Titration
|
Accelerated Oxytocin Titration
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Consent Rate
Time Frame: From screening for eligibility until randomization (up to 5 weeks)
|
|
From screening for eligibility until randomization (up to 5 weeks)
|
Protocol Violation Rate
Time Frame: From admission to a hospital for delivery until delivery (up to 1 week)
|
a) The proportion among those randomized of deviation from study protocol with regards to duration of oxytocin augmentation prior to operative intervention
|
From admission to a hospital for delivery until delivery (up to 1 week)
|
Maternal satisfaction
Time Frame: from hospital admission to 4 weeks postpartum
|
|
from hospital admission to 4 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Caesarean section rate
Time Frame: From admission to a hospital for delivery until delivery (up to 1 week)
|
From admission to a hospital for delivery until delivery (up to 1 week)
|
|
Rate of Maternal and Fetal/Neonatal Adverse Events
Time Frame: From admission to the hospital for delivery until discharge of the baby from the neonatal intensive care unit (up to 4 weeks after birth)
|
|
From admission to the hospital for delivery until discharge of the baby from the neonatal intensive care unit (up to 4 weeks after birth)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jessica Dy, MD, Ottawa Hospital Research Institute
- Principal Investigator: Shu Qin Wei, MD, PhD, Sainte-Justine Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-521
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labour Dystocia
-
Christiana Care Health ServicesCompleted
-
Liz DarlingLondon Health Sciences Centre; Trillium Health Partners; Oak Valley HealthNot yet recruiting
-
Assuta Ashdod HospitalCompleted
-
Ostfold Hospital TrustActive, not recruitingCaesarean Sections | Augmentation With Oxytocin | Labour DystociaNorway
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...Active, not recruitingProgression | Ultrasound Therapy; Complications | Labour;Obstructed | Delivery Problem for FetusTurkey
-
Assiut UniversityBaylor College of Medicine; Middle-Eastern College of Obstetricians and GynecologistsNot yet recruitingPre-Eclampsia | Gestational Diabetes | Labour Dystocia
-
University of LeedsNational Institute of Academic Anaesthesia (NIAA), UK; Obstetric Anaethetists...UnknownPregnancy | Labour | Epidural Block | Primigravida LabourUnited Kingdom
-
Aljazeera HospitalKasr El Aini HospitalUnknown
Clinical Trials on Oxytocin
-
University of Electronic Science and Technology...Completed
-
Hillel Yaffe Medical CenterUnknownCervix; Insufficient Dilatation in LaborIsrael
-
University of NebraskaNational Institute of Mental Health (NIMH)Terminated
-
GlaxoSmithKlineCompletedPostpartum HemorrhageUnited Kingdom
-
University of Electronic Science and Technology...Recruiting
-
GlaxoSmithKlineMonash University; InVentiv CliniqueTerminatedPostpartum HemorrhageAustralia, United Kingdom
-
University Hospital, ToulouseCompleted
-
OptiNose ASUniversity of OsloCompletedHealthy Male AdultsNorway
-
Washington University School of MedicineUniversity of MichiganRecruiting
-
Wake Forest University Health SciencesNational Institute of Neurological Disorders and Stroke (NINDS)CompletedHealthy Volunteer StudyUnited States